# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055347
Filing Date
2021-11-09
Accepted
2021-11-08 18:08:33
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acad-10q_20210930.htm iXBRL | 10-Q | 2282903
2 | EX-31.1 | acad-ex311_8.htm | EX-31.1 | 9491
3 | EX-32.1 | acad-ex321_6.htm | EX-32.1 | 6350
| Complete submission text file | 0001564590-21-055347.txt |  | 7562614

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | acad-20210930.xsd | EX-101.SCH | 41907
5 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | acad-20210930_cal.xml | EX-101.CAL | 56260
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | acad-20210930_def.xml | EX-101.DEF | 102560
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | acad-20210930_lab.xml | EX-101.LAB | 300195
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | acad-20210930_pre.xml | EX-101.PRE | 235228
9 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-10q_20210930_htm.xml | XML | 1535094

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 211389213
SIC: 2834 Pharmaceutical Preparations